EP 2964259 A1 20160113 - USE OF (RS)-S-CYCLOPROPYL-S-(4-{[4-{[(1R,2R)-2-HYDROXY-1-METHYLPROPYL]- OXY}-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]AMINO}PHENYL)SULFOXIMIDE FOR TREATMENT OF SPECIFIC TUMOURS
Title (en)
USE OF (RS)-S-CYCLOPROPYL-S-(4-{[4-{[(1R,2R)-2-HYDROXY-1-METHYLPROPYL]- OXY}-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]AMINO}PHENYL)SULFOXIMIDE FOR TREATMENT OF SPECIFIC TUMOURS
Title (de)
VERWENDUNG VON (RS)-S-CYCLOPROPYL-S-(4-{[4-{[(1R,2R)-2-HYDROXY-1-METHYLPROPYL]OXY}-5-(TRIFLUORMETHYL)PYRIMIDIN-2-YL]AMINO}PHENYL)SULFOXIMID ZUR BEHANDLUNG SPEZIFISCHER TUMORE
Title (fr)
UTILISATION DE (RS)-S-CYCLOPROPYL-S-(4-{[4-{[(1R, 2R)-2-HYDROXY-1-MÉTHYLPROPYL]OXY}-5-(TRIFLUOROMÉTHYL)PYRIMIDIN-2-YL]AMINO}PHÉNYL)SULFOXIMIDE POUR LE TRAITEMENT DE TUMEURS SPÉCIFIQUES
Publication
Application
Priority
- DE 102013203913 A 20130307
- EP 2014053975 W 20140228
Abstract (en)
[origin: WO2014135460A1] The invention relates to the use of (R)-S-cyclopropyl-S-(4-{[4-{[(1R,2R)-2- hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}- phenyl)sulfoximide and/or (S)-S-cyclopropyl-S-(4-{[4-{[(1R,2R)-2- hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}- phenyl)sulfoximide for treatment of specific tumors.
IPC 8 full level
A61K 45/06 (2006.01); A61K 31/505 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01)
CPC (source: EP US)
A61K 31/505 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP)
Citation (search report)
See references of WO 2014135460A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2014135460 A1 20140912; AP 2015008753 A0 20150930; AU 2014224737 A1 20150924; BR 112015021550 A2 20170718; CA 2904149 A1 20140912; CL 2015002491 A1 20160115; CN 105007945 A 20151028; EA 201591625 A1 20160331; EP 2964259 A1 20160113; HK 1211229 A1 20160520; IL 240977 A0 20151130; JP 2016513619 A 20160516; KR 20150128783 A 20151118; MX 2015011800 A 20160108; PH 12015501969 A1 20160118; SG 11201506755X A 20150929; TN 2015000387 A1 20170103; TW 201501712 A 20150116; US 2016045496 A1 20160218
DOCDB simple family (application)
EP 2014053975 W 20140228; AP 2015008753 A 20140228; AU 2014224737 A 20140228; BR 112015021550 A 20140228; CA 2904149 A 20140228; CL 2015002491 A 20150907; CN 201480012856 A 20140228; EA 201591625 A 20140228; EP 14707187 A 20140228; HK 15112124 A 20151209; IL 24097715 A 20150901; JP 2015560632 A 20140228; KR 20157027262 A 20140228; MX 2015011800 A 20140228; PH 12015501969 A 20150904; SG 11201506755X A 20140228; TN 2015000387 A 20150903; TW 103108042 A 20140307; US 201414773656 A 20140228